The latest news from oncology events around the world
The role of ctDNA, or liquid biopsy, as a predictive tool to guide and monitor…
Results from a new phase III study found that combining PD-L1 and TIGIT inhibitors plus…
The addition of durvalumab and bevacizumab to TACE significantly improved progression-free survival in patients with…
A combination of two HER2-targeted drugs, tucatinib (Tukysa) and trastuzumab emtansine (Kadcyla, T-DM1), extended progression-free…
Among patients with metastatic breast cancer, those who took part in a nine-month structured exercise…
Patients with HER2-positive breast cancer that has started to spread to other parts of the…
Patients with breast cancer in conflict zones around the world are being “massively under-served” by…
The majority of people living with advanced breast cancer give up working against their will,…
“Many Australians affected by cancer experience a significant financial burden, which can lead to physical…
Until we capture exhaustive data on treatments and outcomes, more than 10,500 Australians living with…